Actual Medicinal Product (AMP) Tuzulby 40mg prolonged-release chewable tablets (Neuraxpharm UK Ltd)

Stability Information

Stability
not_set logo These medicines have not been reviewed by SPS.
Notes
There are no stability notes available for this medicine.
Generic
Methylphenidate
Formulation
Methylphenidate 40mg modified-release chewable tablets sugar free
  • Methylphenidate
    • Methylphenidate 40mg modified-release chewable tablets sugar free

      • Tuzulby 40mg prolonged-release chewable tablets (Neuraxpharm UK Ltd)



Related Formulations (19)

not_set logo Methylphenidate 5mg tablets
not_set logo Methylphenidate 10mg tablets
not_set logo Methylphenidate 20mg tablets
incompatible logo Methylphenidate 18mg modified-release tablets
incompatible logo Methylphenidate 36mg modified-release tablets
not_set logo Methylphenidate 20mg modified-release tablets
compatible_special_measures logo Methylphenidate 10mg modified-release capsules
compatible_special_measures logo Methylphenidate 20mg modified-release capsules
compatible_special_measures logo Methylphenidate 30mg modified-release capsules
incompatible logo Methylphenidate 27mg modified-release tablets
compatible_special_measures logo Methylphenidate 40mg modified-release capsules
compatible_special_measures logo Methylphenidate 5mg modified-release capsules
compatible_special_measures logo Methylphenidate 50mg modified-release capsules
compatible_special_measures logo Methylphenidate 60mg modified-release capsules
incompatible logo Methylphenidate 54mg modified-release tablets
not_set logo Methylphenidate 20mg modified-release chewable tablets sugar free
not_set logo Methylphenidate 30mg modified-release chewable tablets sugar free
not_set logo Methylphenidate 40mg modified-release chewable tablets sugar free
not_set logo Methylphenidate 45mg modified-release tablets